These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33598259)

  • 1. Addition of levosimendan to overcome acute cardiogenic shock-Paving the way for later heart transplantation-A first case report.
    Flottmann C; Dumitrescu D; Sohns C; Rudolph V; Fox H
    Clin Case Rep; 2021 Feb; 9(2):856-860. PubMed ID: 33598259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levosimendan in the treatment of cardiogenic shock.
    Buerkem B; Lemm H; Krohe K; Dietz S; Raaz U; Buerke U; Russ M; Schlitt A; Werdan K
    Minerva Cardioangiol; 2010 Aug; 58(4):519-30. PubMed ID: 20938415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiogenic shock complicating peripartum cardiomyopathy: Importance of early left ventricular unloading and bromocriptine therapy.
    Sieweke JT; Pfeffer TJ; Berliner D; König T; Hallbaum M; Napp LC; Tongers J; Kühn C; Schmitto JD; Hilfiker-Kleiner D; Schäfer A; Bauersachs J
    Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(2):173-182. PubMed ID: 29792513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock.
    Russ MA; Prondzinsky R; Christoph A; Schlitt A; Buerke U; Söffker G; Lemm H; Swyter M; Wegener N; Winkler M; Carter JM; Reith S; Werdan K; Buerke M
    Crit Care Med; 2007 Dec; 35(12):2732-9. PubMed ID: 17893627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right ventricular function in myocardial infarction complicated by cardiogenic shock: Improvement with levosimendan.
    Russ MA; Prondzinsky R; Carter JM; Schlitt A; Ebelt H; Schmidt H; Lemm H; Heinroth K; Soeffker G; Winkler M; Werdan K; Buerke M
    Crit Care Med; 2009 Dec; 37(12):3017-23. PubMed ID: 19661807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction.
    Fuhrmann JT; Schmeisser A; Schulze MR; Wunderlich C; Schoen SP; Rauwolf T; Weinbrenner C; Strasser RH
    Crit Care Med; 2008 Aug; 36(8):2257-66. PubMed ID: 18664782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
    Schumann J; Henrich EC; Strobl H; Prondzinsky R; Weiche S; Thiele H; Werdan K; Frantz S; Unverzagt S
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009669. PubMed ID: 29376560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Levosimendan on Systemic Perfusion in Patients with Low Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) Score: Experience from a Single Center in Taiwan.
    Wang YH; Chen JL; Tsai CS; Tsai YT; Lin CY; Ke HY; Hsu PS
    Acta Cardiol Sin; 2021 Sep; 37(5):512-521. PubMed ID: 34584384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Levosimendan Administration Improved Weaning Success Rate in Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock.
    Chen YW; Lee WC; Wu PJ; Fang HY; Fang YN; Chen HC; Tong MS; Sung PH; Lee CH; Chung WJ
    Front Cardiovasc Med; 2022; 9():912321. PubMed ID: 35845047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines.
    Delle Karth G; Buberl A; Geppert A; Neunteufl T; Huelsmann M; Kopp C; Nikfardjam M; Berger R; Heinz G
    Acta Anaesthesiol Scand; 2003 Nov; 47(10):1251-6. PubMed ID: 14616323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levosimendan as rescue therapy in severe cardiogenic shock after ST-elevation myocardial infarction.
    Greif M; Zwermann L; Reithmann C; Weis M
    Acute Card Care; 2008; 10(3):185-90. PubMed ID: 18972629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis.
    Guilherme E; Jacquet-Lagrèze M; Pozzi M; Achana F; Armoiry X; Fellahi JL
    Crit Care; 2020 Jul; 24(1):442. PubMed ID: 32677985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of refractory vasospastic angina complicated by acute pulmonary oedema with levosimendan: a case report.
    Moltrasio M; Cosentino N; Conte E; Campodonico J; Marenzi G
    Eur Heart J Case Rep; 2019 Mar; 3(1):ytz002. PubMed ID: 31020247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report: a patient with thyroid storm, refractory cardiogenic shock, and cardiac arrest treated with Lugol's iodine solution and veno-arterial extra corporal membrane oxygenation support.
    Voll M; Øystese KA; Høiskar E; Johansen O; Nyvold C; Norheim I; von Lueder TG; Andersen GØ
    Eur Heart J Case Rep; 2021 Feb; 5(2):ytab017. PubMed ID: 33569532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Successful use of levosimendan in a patient with cardiogenic shock complicating acute myocardial infarction].
    Mustapha F; Moufida H; Nedia B; Anis L; Iheb L; Habib H
    Tunis Med; 2005 Oct; 83(10):635-7. PubMed ID: 16370217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of Levosimendan on global haemodynamics in patients with cardiogenic shock.
    Rokyta R; Pechman V
    Neuro Endocrinol Lett; 2006; 27(1-2):121-7. PubMed ID: 16648778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion.
    Nieminen MS; Buerke M; Cohen-Solál A; Costa S; Édes I; Erlikh A; Franco F; Gibson C; Gorjup V; Guarracino F; Gustafsson F; Harjola VP; Husebye T; Karason K; Katsytadze I; Kaul S; Kivikko M; Marenzi G; Masip J; Matskeplishvili S; Mebazaa A; Møller JE; Nessler J; Nessler B; Ntalianis A; Oliva F; Pichler-Cetin E; Põder P; Recio-Mayoral A; Rex S; Rokyta R; Strasser RH; Zima E; Pollesello P
    Int J Cardiol; 2016 Sep; 218():150-157. PubMed ID: 27232927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and Design of JenaMACS-Acute Hemodynamic Impact of Ventricular Unloading Using the Impella CP Assist Device in Patients with Cardiogenic Shock.
    Haertel F; Lenk K; Fritzenwanger M; Pfeifer R; Franz M; Memisevic N; Otto S; Lauer B; Weingärtner O; Kretzschmar D; Dannberg G; Westphal J; Baez L; Bogoviku J; Schulze PC; Moebius-Winkler S
    J Clin Med; 2022 Aug; 11(15):. PubMed ID: 35956238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staged approach to mechanical circulatory support and recovered allograft function after transplantation rejection with cardiogenic shock.
    Caceres M; Czer LS; Esmailian F; Luthringer D; Ramzy D; Moriguchi J
    Tex Heart Inst J; 2013; 40(5):596-9. PubMed ID: 24391334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on levosimendan in acute cardiac care: applications and recommendations for optimal efficacy and safety.
    Heringlake M; Alvarez J; Bettex D; Bouchez S; Fruhwald S; Girardis M; Grossini E; Guarracino F; Herpain A; Toller W; Tritapepe L; Pollesello P
    Expert Rev Cardiovasc Ther; 2021 Apr; 19(4):325-335. PubMed ID: 33739204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.